This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, L. Articles by Wei, Q. Search for Related Content PubMed PubMed Citation Articles by Wang, L. Articles by Wei, Q.

Association of Genetic Variants of O⁶-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Qingyi Wei, Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Unit 1365, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-3020; Fax: 713-792-0807. E-mail: qwei{at}mdanderson.org

O⁶-methylguanine, a methylated damage lesion in DNA, correlates with spontaneous G:C A:T transition mutations and leads to activation of oncogene K-ras or dysfunction of the tumor suppressor gene p53. O⁶-methylguanine-DNA methyltransferase (MGMT) is critical for repairing damage to the O⁶-position of guanine. Therefore, we tested our hypothesis that genetic variants of MGMT are associated with increased lung cancer risk in a Caucasian population of 1,121 lung cancer patients and 1,163 matched cancer-free controls. We genotyped four potentially functional single nucleotide polymorphisms (SNPs) of MGMT: exon 3 codon 84C T (L84F), exon 5 codon 143A G (I143V), and two promoter SNPs 135G T and 485C A. The allele frequency distributions of the SNPs of codon 84C T and the promoter 135G T in the cases were borderline different from that in the controls. After defining the minor allele (T for codon 84C T and G for codon 143A G) as the variant allele, we categorized the MGMT genotypes as either 0 variants (84CC-143AA) or 1-4 variants. Compared with 0 variants, those with 1-4 variants showed a statistically significantly increased risk of lung cancer (P = 0.040). Further stratification analysis showed that this increased risk was more pronounced in women, current smokers, and non–small cell lung cancer. We did not find any association between the MGMT promoter SNPs and lung cancer risk. Our findings suggest that non-synonymous SNPs in MGMT are associated with modestly increased risk of lung cancer in Caucasians and need to be further investigated. (Cancer Epidemiol Biomarkers Prev 2006;15(12):2364–9)